Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7141 AL 7155

Is lithium a neuroprotective agent?

Vo TM, Perry P, Ellerby M, Bohnert K.

Ann Clin Psychiatry. 2015 Feb;27(1):49-54.

[New therapeutic approaches]

Kurz A, Grimmer T.

Ther Umsch. 2015 Apr;72(4):279-85. doi: 10.1024/0040-5930/a000676.

Ferulic acid and Alzheimer's disease: promises and pitfalls

Nabavi SF, Devi KP, Malar DS, Sureda A, Daglia M, Nabavi SM.

Mini Rev Med Chem. 2015;15(9):776-88. doi: 10.2174/1389557515666150522102545.

Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases

Fernández-Moriano C, González-Burgos E, Gómez-Serranillos MP.

Oxid Med Cell Longev. 2015;2015:408927. doi: 10.1155/2015/408927. Epub 2015 Apr 29.

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease

Cummings J, Zhong K.

Clin Pharmacol Ther. 2015 Nov;98(5):483-5. doi: 10.1002/cpt.190. Epub 2015 Aug 31.

Purinergic receptors as potential therapeutic targets in Alzheimer's disease

Woods LT, Ajit D, Camden JM, Erb L, Weisman GA.

Neuropharmacology. 2016 May;104:169-79. doi: 10.1016/j.neuropharm.2015.10.031. Epub 2015 Oct 28.

Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer's and Parkinson's Disease

Soursou G, Alexiou A, Ashraf GM, Siyal AA, Mushtaq G, Kamal MA.

Curr Drug Metab. 2015;16(8):705-12. doi: 10.2174/138920021608151107125049.

Biparietal variant of Alzheimer's disease: a rare presentation of a common disease

Marques IB, Tábuas-Pereira M, Milheiro M, Santana I.

BMJ Case Rep. 2015 Jan 5;2015:bcr2014207011. doi: 10.1136/bcr-2014-207011.

Flavonoid-based therapies in the early management of neurodegenerative diseases

Solanki I, Parihar P, Mansuri ML, Parihar MS.

Adv Nutr. 2015 Jan 15;6(1):64-72. doi: 10.3945/an.114.007500. Print 2015 Jan.

Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease

Akagi M, Matsui N, Akae H, Hirashima N, Fukuishi N, Fukuyama Y, Akagi R.

J Pharmacol Sci. 2015 Feb;127(2):155-63. doi: 10.1016/j.jphs.2014.12.015. Epub 2015 Jan 13.

Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others

Fernández-Ruiz J, Romero J, Ramos JA.

Handb Exp Pharmacol. 2015;231:233-59. doi: 10.1007/978-3-319-20825-1_8.

Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis

Beauchet O, Launay CP, Montero-Odasso M, Annweiler C, Allali G.

Curr Alzheimer Res. 2015;12(8):761-71. doi: 10.2174/1567205012666150710111341.

Changes in gait variability with anti-dementia drugs: a systematic review and meta-analysis

Beauchet O, Launay CP, Allali G, Annweiler C.

CNS Drugs. 2014 Jun;28(6):513-8. doi: 10.1007/s40263-014-0170-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias